$3.57 +0.01 (0.14%) Regulus Therapeutic Inc - NASDAQ

Jul. 29, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 3.57
Trade Time: Jul 29 04:00 PM Eastern Daylight Time
Change: +0.01 (0.14%)
Prev Close: 3.57
Open: 3.53
Bid: 3.56
Ask: 3.57
  1. No results found.
  1. Regulus to Present Additional Preclinical Data Supporting RG-012 as a Novel microRNA Therapeutic in Development for Alport Syndrome at ASN's Kidney Week 2015

    Benzinga | Oct. 5, 2015 | 16:06PM EST
  2. Regulus Initiates Phase I Clinical Study of RG-012, a microRNA Therapeutic in Development for the Treatment of Alport Syndrome

    Benzinga | Jun. 4, 2015 | 08:04AM EST
  3. Weekly CEO Sells Highlight: Hovnanian Enterprises Inc, Regulus Therapeutics Inc, Monster ...

    GuruFocus | Apr. 27, 2015 | 02:34AM EST
  4. Benzinga's Top Initiations

    Benzinga | Apr. 21, 2015 | 09:36AM EST
  5. Is Regulus Preparing For A Huge Breakout?

    Benzinga | Feb. 23, 2015 | 15:24PM EST
  6. Wedbush Continues Outperform Rating on Regulus

    Benzinga | Feb. 19, 2015 | 19:29PM EST
  7. Regulus Therapeutics Falls 12% Following HCV Clinical Study Results

    Benzinga | Feb. 9, 2015 | 13:19PM EST
  8. Morning Market Losers

    Benzinga | Feb. 9, 2015 | 10:00AM EST
  9. Monday Morning Movers: Achillion Up, Regulus Down Following Drug Results

    Benzinga | Feb. 9, 2015 | 09:05AM EST
  10. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 9, 2015 | 08:14AM EST
  11. HCV Stocks Struggle As Gilead, Merck Face Headwinds

    IBD | Feb. 4, 2015 | 12:12PM EST
  12. Weekly CEO Sells Highlight: Kimberly-Clark Corp, Regulus Therapeutics Inc, Prologis Inc, and ...

    GuruFocus | Feb. 1, 2015 | 22:49PM EST
  13. What Investors Are Watching For In Regulus Therapeutics' Next Data Release

    Benzinga | Jan. 30, 2015 | 14:32PM EST
  14. Morning Market Movers

    Benzinga | Jan. 2, 2015 | 09:39AM EST
  15. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 2, 2015 | 08:38AM EST
Trading Center